Header Logo

Connection

Debra Ritzwoller to Neoplasms

This is a "connection" page, showing publications Debra Ritzwoller has written about Neoplasms.
Connection Strength

2.599
  1. The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes. J Natl Cancer Inst. 2023 08 08; 115(8):886-895.
    View in: PubMed
    Score: 0.625
  2. Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions. J Natl Cancer Inst Monogr. 2022 Jul 05; 2022(59):42-50.
    View in: PubMed
    Score: 0.580
  3. Advanced imaging among health maintenance organization enrollees with cancer. J Oncol Pract. 2014 Jul; 10(4):231-8.
    View in: PubMed
    Score: 0.330
  4. Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
    View in: PubMed
    Score: 0.316
  5. Cancer Survivorship and Supportive Care Economics Research: Current Challenges and Next Steps. J Natl Cancer Inst Monogr. 2022 Jul 05; 2022(59):57-63.
    View in: PubMed
    Score: 0.145
  6. Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 10; 151:106595.
    View in: PubMed
    Score: 0.135
  7. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323.
    View in: PubMed
    Score: 0.097
  8. When does an episode of care for cancer begin? Med Care. 2013 Apr; 51(4):324-9.
    View in: PubMed
    Score: 0.076
  9. The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system. J Natl Cancer Inst Monogr. 2013; 2013(46):99-105.
    View in: PubMed
    Score: 0.075
  10. A standardized relative resource cost model for medical care: application to cancer control programs. J Natl Cancer Inst Monogr. 2013; 2013(46):106-16.
    View in: PubMed
    Score: 0.075
  11. Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr. 2013; 2013(46):124-30.
    View in: PubMed
    Score: 0.075
  12. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
    View in: PubMed
    Score: 0.071

© 2024 Kaiser Permanente